Follow
Matthias I Gröschel
Matthias I Gröschel
Harvard Medical School
Verified email at hms.harvard.edu - Homepage
Title
Cited by
Cited by
Year
ESX secretion systems: mycobacterial evolution to counter host immunity
MI Gröschel, F Sayes, R Simeone, L Majlessi, R Brosch
Nature Reviews Microbiology 14 (11), 677-691, 2016
3552016
Cytosolic Access of Mycobacterium tuberculosis: Critical Impact of Phagosomal Acidification Control and Demonstration of Occurrence In Vivo
R Simeone, F Sayes, O Song, MI Gröschel, P Brodin, R Brosch, L Majlessi
PLoS pathogens 11 (2), e1004650, 2015
2242015
Recombinant BCG expressing ESX-1 of Mycobacterium marinum combines low virulence with cytosolic immune signaling and improved TB protection
MI Gröschel, F Sayes, SJ Shin, W Frigui, A Pawlik, M Orgeur, R Canetti, ...
Cell reports 18 (11), 2752-2765, 2017
1102017
The phylogenetic landscape and nosocomial spread of the multidrug-resistant opportunist Stenotrophomonas maltophilia
MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ...
Nature communications 11 (1), 2044, 2020
912020
Targeting multidrug-resistant tuberculosis (MDR-TB) by therapeutic vaccines
SA Prabowo, MI Gröschel, EDL Schmidt, A Skrahina, T Mihaescu, ...
Medical microbiology and immunology 202, 95-104, 2013
912013
Therapeutic vaccines for tuberculosis—a systematic review
MI Gröschel, SA Prabowo, PJ Cardona, JL Stanford, TS Van der Werf
Vaccine 32 (26), 3162-3168, 2014
862014
Non-steroidal anti-inflammatory drugs as host-directed therapy for tuberculosis: a systematic review
VM Kroesen, MI Gröschel, N Martinson, A Zumla, M Maeurer, ...
Frontiers in immunology 8, 772, 2017
762017
CD4+ T Cells Recognizing PE/PPE Antigens Directly or via Cross Reactivity Are Protective against Pulmonary Mycobacterium tuberculosis Infection
F Sayes, A Pawlik, W Frigui, MI Gröschel, S Crommelynck, C Fayolle, ...
PLoS pathogens 12 (7), e1005770, 2016
652016
Pathogen-based precision medicine for drug-resistant tuberculosis
MI Gröschel, TM Walker, TS van der Werf, C Lange, S Niemann, M Merker
PLoS pathogens 14 (10), e1007297, 2018
582018
Type VII secretion systems in Gram-positive bacteria
D Bottai, MI Gröschel, R Brosch
Protein and sugar export and assembly in Gram-positive bacteria, 235-265, 2017
572017
Perspectives for personalized therapy for patients with multidrug‐resistant tuberculosis
C Lange, WA Alghamdi, MH Al‐Shaer, S Brighenti, AH Diacon, ...
Journal of internal medicine 284 (2), 163-188, 2018
472018
Multiplexed quantitation of intraphagocyte Mycobacterium tuberculosis secreted protein effectors
F Sayes, C Blanc, LS Ates, N Deboosere, M Orgeur, F Le Chevalier, ...
Cell Reports 23 (4), 1072-1084, 2018
392018
GenTB: A user-friendly genome-based predictor for tuberculosis resistance powered by machine learning
MI Gröschel, M Owens, L Freschi, R Vargas, MG Marin, J Phelan, Z Iqbal, ...
Genome medicine 13, 1-14, 2021
322021
Prioritising children and adolescents in the tuberculosis response of the WHO European Region
MI Gröschel, M van den Boom, GB Migliori, M Dara
European Respiratory Review 28 (151), 2019
282019
A convolutional neural network highlights mutations relevant to antimicrobial resistance in Mycobacterium tuberculosis
AG Green, CH Yoon, ML Chen, Y Ektefaie, M Fina, L Freschi, MI Gröschel, ...
Nature communications 13 (1), 3817, 2022
262022
A diagnostic algorithm to investigate pyrazinamide and ethambutol resistance in rifampin-resistant Mycobacterium tuberculosis isolates in a low-incidence setting
S Andres, MI Gröschel, D Hillemann, M Merker, S Niemann, K Kranzer
Antimicrobial Agents and Chemotherapy 63 (2), 10.1128/aac. 01798-18, 2019
252019
Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection
R van Altena, S Duggirala, M IP Groschel, T S van der Werf
Current pharmaceutical design 17 (27), 2853-2862, 2011
222011
Detection of low-frequency resistance-mediating SNPs in next-generation sequencing data of Mycobacterium tuberculosis complex strains with binoSNP
V Dreyer, C Utpatel, TA Kohl, I Barilar, MI Gröschel, S Feuerriegel, ...
Scientific Reports 10 (1), 7874, 2020
182020
The phylogenetic landscape and nosocomial spread of the multidrugresistant opportunist Stenotrophomonas maltophilia. Nat Commun 11: 2044
MI Gröschel, CJ Meehan, I Barilar, M Diricks, A Gonzaga, M Steglich, ...
182020
Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
J Domínguez, MJ Boeree, E Cambau, D Chesov, F Conradie, V Cox, ...
The Lancet Infectious Diseases 23 (4), e122-e137, 2023
172023
The system can't perform the operation now. Try again later.
Articles 1–20